A more recent preclinical study demonstrated that in atherosclerotic mice with apolipoprotein E deficiency (ApoE−/−), exogenous FSH supplementation could accelerate atherosclerosis progression, through macrophage activation, increasing the expression and secretion of IL-1β, and, therefore, worsening atherosclerotic lesions [49]. This evidence concerns the gene BRD2 and atherosclerosis.